


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.31%
+2.91%
+0.18%
+9.56%
MRNA
Moderna
$45.37

Login to see Moderna (MRNA) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive
MRNA Price Performance
$48.77 (-6.97%)
$40.87 (+11.01%)
$27.97 (+62.21%)
$24.86 (+82.50%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a weak earnings
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
MRNA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MRNA Street Sentiment is extremely bullish and have positive views on the near-term outlook
MRNA has Medium risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Apr 23, 2026
Price Target Raised
Buy
Jefferies
Nov 22, 2025
Reiterate
Overweight
Piper Sandler
Apr 16, 2026
Price Target Raised
Buy
Morgan Stanley
Jan 06, 2026
Downgrade
Neutral
UBS
GILD
Gilead Sciences
131.65
+0.62%
AMGN
Amgen
329.82
-4.75%
DTIL
Precision BioScience
7.28
+1.82%
ALLO
Allogene Therapeutics
2.15
+0.94%
BNTX
BioNTech
97.54
-5.71%
What is MRNA current stock price?
What are MRNA stock strengths?
What is MRNA Risk Level?
What is MRNA market cap and volume?
What is MRNA current Stock IQ?
Should I buy MRNA stock right now?
Is MRNA a Strong Buy right now?
What does a 'Strong Buy' rating mean for MRNA?
What does a 'Strong Sell' rating mean for MRNA?
What factors influence MRNA's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Recently Viewed
Most Trending
MRNA
Moderna
Current Price
$45.37
Runners Also Watch
GILD
Gilead Sciences
131.65
+0.62%
AMGN
Amgen
329.82
-4.75%
DTIL
Precision BioScience
7.28
+1.82%
ALLO
Allogene Therapeutics
2.15
+0.94%
BNTX
BioNTech
97.54
-5.71%

MRNA Price Performance
$48.77 (-6.97%)
$40.87 (+11.01%)
$27.97 (+62.21%)
$24.86 (+82.50%)
MRNA Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a weak earnings
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors confidence is positive
Future
Future
Earnings are forecast to grow
MRNA Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MRNA Street Sentiment is extremely bullish and have positive views on the near-term outlook
MRNA has Medium risk level

Overall Wall Street Rating
MRNA Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Investors confidence is positive
MRNA Trading Signals
MRNA is showing high volatility with an intraday swing of 10.81% (High: $48.40, Low: $43.68). This signals potential risk.
MRNA has negative earnings news: Missed Estimate. Moderna Inc. (NASDAQ:MRNA) Q1 2026 Earnings Call Transcript. Moderna Inc. (NASDAQ: MRNA ) Q1 2026 Earnings Call Transcript May 1 2026 Moderna Inc. mis...
MRNA has positive earnings news: Beat Estimates. Moderna Beats Estimates on Covid Vaccine Sales Outside US. Moderna Inc.s first-quarter sales beat expectations as the struggling vaccine maker thats f...
MRNA beat earnings expectations. Moderna Beats Estimates on Covid Vaccine Sales Outside US. Moderna Inc.s first-quarter sales beat expectations as the struggling vaccine maker thats f...
MRNA missed earnings expectations. Moderna Inc. (NASDAQ:MRNA) Q1 2026 Earnings Call Transcript. Moderna Inc. (NASDAQ: MRNA ) Q1 2026 Earnings Call Transcript May 1 2026 Moderna Inc. mis...
MRNA received an analyst price target change. RBC Capital raises Moderna stock price target on Q1 beat....
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MRNA Stock trends
MRNA Stock performance
MRNA Stock analysis
MRNA investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.